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Abstract  
 
APOE-e4 is a main genetic risk factor for developing late onset Alzheimer’s disease (LOAD) 
and is thought to interact adversely with other risk factors on the brain. However, evidence 
regarding the impact of APOE-e4 on grey matter structure in asymptomatic individuals 
remains mixed. Much attention has been devoted to characterising APOE-e4-related 
changes in the hippocampus, but LOAD pathology is known to spread through the whole of 
the Papez circuit including the limbic thalamus. Here, we tested the impact of APOE-e4 and 
two other risk factors, a family history of dementia and obesity, on grey matter macro- and 
microstructure across the whole brain in 165 asymptomatic individuals (38-71 years). 
Microstructural properties of apparent neurite density and dispersion, free water, myelin and 
cell metabolism were assessed with Neurite Orientation Density and Dispersion (NODDI) 
and quantitative magnetization transfer (qMT) imaging. APOE-e4 carriers relative to non-
carriers had a lower macromolecular proton fraction (MPF) in the left thalamus. No risk 
effects were present for cortical thickness, subcortical volume, or NODDI indices. Reduced 
thalamic MPF may reflect inflammation-related tissue swelling and/or myelin loss in APOE-
e4. Future prospective studies should investigate the sensitivity and specificity of qMT-based 
MPF as a non-invasive biomarker for LOAD risk. 
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1. Introduction  
 
As the global population ages, an increasing number of people over 65 will develop 
dementia due to late onset Alzheimer’s disease (LOAD) 1. LOAD is characterized by the 
development of amyloid-b plaques and neurofibrillary tau tangles that spread from limbic 
regions to neocortical areas 2-4. As these pathological processes are thought to accumulate 
over many years 5, it may be possible to identify brain changes related to heightened risk in 
asymptomatic individuals prior to the onset of memory impairment.  
Carriage of the Apolipoprotein E (APOE)-e4 genotype is the best-established genetic 
risk factor of LOAD 6, 7.  APOE is the main cholesterol carrier in the brain that supports lipid 
transport, myelination, synaptic repair and the regulation of amyloid-b aggregation and 
clearance 8. Individuals who carry the APOE-e4 isoform compared to those with APOE-e2  
and -e3 show an earlier onset of LOAD 6, 9 and a larger burden of amyloid-β plaques 10-14. 
Such harmful effects of APOE-e4 are heightened in individuals with a family history of LOAD 
15, 16, probably due to the presence of other polygenetic risk variants such as those of 
TREM2 17, 18. In addition, APOE-e4 is known to combine adversely with lifestyle-related risk 
notably central obesity 19, 20. Excessive abdominal visceral fat can lead to the metabolic 
syndrome, type 2 diabetes, and cardiovascular disease 21 and obese APOE-e4 carriers are 
more likely to develop hypertension, inflammation and insulin resistance 22, 23.   
Much attention has been devoted to characterizing APOE-e4-related changes in 
medial temporal lobe regions, notably in the hippocampus and parahippocampal regions 24 
25, 26 due to their importance for episodic memory. Hippocampal volume loss on magnetic 
resonance imaging (MRI) is also one of the diagnostic biomarkers of LOAD 27. However, 
hippocampal atrophy is lacking in specificity 28 and usually occurs in more advanced disease 
stages 29. Indeed, evidence regarding hippocampal atrophy in APOE-e4 carriers is mixed 
and is often thought to result from the inclusion of older participants with underlying LOAD 
pathology 30, 31. It, therefore, stands to reason that hippocampal volume loss may not be 
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sufficiently sensitive to detect very early disease changes and it has been proposed that 
focusing on specific hippocampal subregions such as CA1 and subiculum may be more 
promising 32, 33. However, it is also possible that limbic regions other than the hippocampus 
may play an important role in the development of LOAD. Notably, it has been recognised for 
a while that LOAD pathology may spread through the whole of the Papez circuit and may 
critically involve the limbic thalamus 4. For instance, neurofibrillary accumulations in the 
anterodorsal thalamic nucleus have been found at the same time as those in the 
hippocampus in LOAD brains 34 and reduced thalamic MRI volume has been observed in 
amnestic Mild Cognitive Impairment (MCI) 35, LOAD 36 and presymptomatic presenilin 1 
mutation carriers 37. Similarly, Positron Emission Tomography (PET) studies have found 
APOE-e4 state to accelerate longitudinal reductions in glucose metabolism in the thalamus 
and frontal, parietal, and posterior cingulate regions in MCI 38. Reduced glucose metabolism 
in anterior and posterior cingulate cortices, retrosplenial, precuneus, parietal cortex, 
hippocampus and thalamus was also observed in cognitively healthy middle-aged APOE-e4 
carriers 39, suggesting that metabolic tissue changes in regions beyond the hippocampus 
can already occur at asymptomatic stages 40.  
While PET imaging is sensitive to metabolic changes and can identify amyloid-b and 
tau burden 41, it is invasive and expensive and, therefore, difficult to scale up. Recent 
advances in non-invasive multi-parametric quantitative MRI (qMRI) methods can reveal 
subtle microstructural brain changes and promise to provide alternative imaging markers 
that may be sensitive to early risk-related changes. Up to now qMRI measurements have 
primarily been studied in LOAD patients and animal models, thus evidence with regards to 
the effects of risk factors in asymptomatic individuals is sparse. 
 
Insert Table 1 and 2 here  
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To address this gap in the literature, we went beyond morphological analyses by 
employing multi-parametric qMRI to study the effects of APOE-e4, Family History (FH) of 
dementia and obesity on cortical and subcortical grey matter in 165 asymptomatic 
individuals from the Cardiff Ageing and Risk of Dementia Study (CARDS) 42-44 (Table 1). 
More specifically we applied indices sensitive to neurite dispersion and density, free water, 
myelin and cell metabolism from Neurite Orientation Density and Dispersion Imaging 
(NODDI) 45, quantitative magnetization transfer (qMT) 46-49 and T1-relaxometry 50 (Table 2).  
NODDI fits a three-compartment biophysical tissue model to diffusion-weighted data 
acquired with a two-shell (b-values of 1200 s/mm2 and 2400 s/mm2) High Angular Resolution 
Diffusion Imaging (HARDI) 51 protocol to separate isotropic from intra- and extracellular 
diffusion compartments 45. This allows the calculation of the isotropic signal fraction (ISOSF), 
an estimate of free water, and the intracellular signal fraction (ICSF), i.e. the fraction of the 
tissue comprised of neurites. In addition, NODDI yields the orientation dispersion index 
(ODI) that reflects the spatial configuration of neurite structures (Table 2). Recent studies 
reported ICSF and ODI reductions in grey and white matter of patients with MCI, LOAD and 
young onset AD 52-54. For instance, Fu et al. (2019) found decreased ICSF and ODI in the 
corpus callosum in MCI and LOAD patients, while Colgan et al. 55 reported positive 
correlations between ICSF and histological measurements of hyperphosphorylated tau 
protein in the hippocampus of rTg4510 mice. 
The qMT method models the exchange rate between macromolecular protons and 
protons in surrounding free water when macromolecular protons are selectively saturated by 
a radiofrequency pulse with a frequency that is off-resonance for protons in free water 46-49. 
This allows the quantification of a number of parameters including the macromolecular 
proton fraction (MPF) and the magnetization transfer exchange rate kf 56. In combined 
neuroimaging and histology studies of Shiverer mice and puppies57-59, MPF has been shown 
to be highly sensitive to the myelin content in white matter such that MPF increases with the 
amount of myelin. MPF in the anterior hippocampus was also found to distinguish healthy 
controls from MCI and LOAD patients 60. Furthermore, MCI and LOAD patients exhibit a 
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reduced rate of magnetization transfer kf in grey and white matter 60-62 suggesting reduced 
cell metabolism 61. Finally, indices from relaxometry imaging such as the longitudinal 
relaxation rate R1 have been proposed as non-invasive biomarkers of LOAD 63.  R1 values 
are influenced by microstructural characteristics such as tissue density, macromolecular, 
protein and lipid composition, and paramagnetic atoms. A number of patient and preclinical 
studies have reported increases in R1 that may reflect LOAD pathology, although the precise 
mechanisms underpinning these changes remain unknown (see for review 63). 
Here, we characterised age and risk-related differences in mean values of ICSF, 
ISOSF, ODI, MPF, kf and R1 across cortical and subcortical grey matter regions that were 
segmented from T1- weighted images with the FreeSurfer image analysis suite (version 5.3) 
64. Microstructural changes were compared with differences in standard morphological 
metrics of cortical thickness and subcortical volumes. We expected to see risk effects in 
brain regions known to be early affected in LOAD including limbic regions of the 
hippocampus, parahippocampus, entorhinal cortex, posterior cingulate cortex as well as 
thalamus 2, 4, 34, 65. We hypothesised that APOE-e4, a positive FH, and central obesity 
[measured with the Waist-Hip-Ratio (WHR)] would be associated with reduced ICSF, R1, 
MPF and kf as well as with increased ISOSF and ODI but with no differences in cortical 
thickness and/or subcortical volume. In addition, we expected to see the largest differences 
in those individuals at greatest risk, i.e. in obese APOE-e4 carriers with a positive FH. 
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2. Results 
 
Microstructural and morphological dependent variables were fitted to a general linear 
model in SPSS version 26 66. All data were examined for outliers defined as above or below 
three times of the interquartile range (75th percentile value - 25th percentile value). This led 
to an exclusion of 0.6% of the microstructural but no exclusions of the morphological data. 
Separate multivariate analyses of covariance (MANCOVA) were carried out to test 
for the effects of APOE genotype (e4+, e4-), FH (FH+, FH-) and WHR (WHR+, WHR-) on 
brain morphology (cortical thickness and subcortical volume measures) and on each of the 
microstructural indices (MPF, kf, R1, ISOSF, ICSF, ODI) across 68 cortical and 14 
subcortical regions of interest, whilst controlling for age, sex, and IQ estimates from the 
revised National Adult Reading Test (NART-R) 67. Significant omnibus effects were further 
investigated with post-hoc comparisons across all outcome measures. All first and post-hoc 
models were corrected for multiple comparisons with a False Discovery Rate (FDR) of 5% 
using the Benjamini-Hochberg procedure 68 (pBHadj).  As the aim of the study was to explore 
microstructural indices that could potentially provide novel biomarkers of dementia risk in 
future studies, a false positive rate of below 5% was regarded as an acceptable threshold to 
control for false positives while minimising the risk of missing any true risk-related 
microstructural differences. Information about effects sizes was provided with the partial eta 
squared index hp2 for MANCOVA analyses, Cohen’s dz for group comparisons and 
Pearson’s r for correlational analyses. 
 
Insert Tables 3-6 and Figures 1-3 here 
 
2.1 MANCOVAs of microstructural qMT metrics 
 
MPF omnibus effects: There were main effects of sex [F(78,46) = 2.2, pBHadj = 0.015, 
hp2 = 0.8] and of APOE genotype [F(78,46) = 2.6, pBHadj < 0.001, hp2 = 0.8] but not of FH 
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(pBHadj = 0.137), WHR (pBHadj = 0.348), age (pBHadj = 0.385) or NART-IQ (pBHadj = 0.497). There 
were no interaction effects between APOE and FH (pBHadj = 1.000), APOE and WHR (pBHadj = 
0.974), FH and WHR (pBHadj = 1.000) or APOE, FH and WHR (pBHadj = 0.935).  
MPF post-hoc effects: APOE-e4 carriers relative to non-carriers had lower MPF in the 
left thalamus (Table 3) (Figure 1). Women had higher MPF than men in the left and right 
rostral middle frontal cortices, in the left superior temporal cortex and the right transverse 
temporal cortex (Table 3) (Figure 2).  
R1 omnibus effects: A significant omnibus effect was only observed for APOE 
genotype [F(82,43) = 2.1, pBHadj = 0.040, hp2 = 0.08]. No main effects were present for FH 
(pBHadj = 0.215), WHR (pBHadj = 0.167), age (pBHadj = 0.085) sex (pBHadj = 0.060) or NART-IQ 
(pBHadj = 0.866) and no interaction effects between APOE and FH (pBHadj = 0.256), APOE and 
WHR (pBHadj = 0.582), FH and WHR (pBHadj = 0.782) or APOE, FH and WHR (pBHadj = 0.548) 
were observed.  
R1 post-hoc effects: No APOE post-hoc effects survived FDR correction (see 
Supplementary Table 1). 
kf omnibus effects: There were no significant main effects of APOE (pBHadj = 0.813), 
FH (pBHadj = 0.908), WHR (pBHadj = 1.000), age (pBHadj = 0.075), sex (pBHadj = 0.975) or NART-
IQ (pBHadj = 0.870) and no interaction effects between APOE and FH (pBHadj = 0.888), APOE 
and WHR (pBHadj = 0.840), FH and WHR (pBHadj = 0.090) or APOE, FH and WHR (pBHadj = 
0.436). 
 
2.2 MANCOVAs of microstructural NODDI metrics 
 
ISOSF omnibus effects: There were main effects for age [F(78,42) = 2.0, pBHadj = 
0.03, hp2 = 0.8], sex [F(78,42) = 3.4, pBHadj < 0.001, hp2 = 0.9], and NART-IQ [F(78,42) = 2.2, 
pBHadj = 0.020, hp2 = 0.8]. No main effects were present for the risk factors of APOE (pBHadj = 
1.000), FH (pBHadj = 0.060) or WHR (pBHadj = 0.717) and no interaction effects between APOE 
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and FH (pBHadj = 0.374), APOE and WHR (pBHadj = 0.551), FH and WHR (pBHadj = 0.986) or 
APOE, FH and WHR (pBHadj = 0.678) were observed. 
ISOSF post-hoc effects: Ageing was associated with bilateral increases in ISOSF in 
medial regions including the cingulate, precuneus and cuneus cortices and in lateral regions 
including superior temporal, supramarginal, postcentral, pars opercularis and insula cortices. 
Age-related increases in ISOSF were also observed in left middle temporal and pars 
triangularis regions as well as in subcortical hippocampi, thalami, nuclei accumbens and 
right putamen (Table 4) (Figure 3). Men relative to women had higher ISOSF in widespread 
frontal, temporal, parietal and cingulate cortices and in caudate nuclei, hippocampi, thalami 
and right nucleus accumbens (Table 4) (Figure 2). In addition, NART-IQ correlated positively 
with ISOSF in the superior temporal sulci (left: r = 0.253, pBHadj = 0.008; right: r = 0.241, pBHadj 
= 0.006), left superior parietal (r = 0.227, pBHadj = 0.006), and right lingual (r = 0.182, pBHadj = 
0.026) cortices (Table 4). After partialling out of age only correlations on the left hemisphere 
remained significant [superior parietal cortex [(r = 0.206, pBHadj = 0.048), superior temporal 
sulcus (r = 0.197, pBHadj = 0.032)] but those on the right did not [superior temporal sulcus 
(pBHadj = 0.053), lingual (pBHadj = 0.08)]. 
ODI omnibus effects: There was a significant main effect of age [F(78,51) = 2.0, 
pBHadj = 0.040, hp2 = 0.8] and a significant interaction effect between FH and WHR [F(78,51) 
= 2.3, pBHadj = 0.010, hp2 = 0.8] but no main effects for sex (pBHadj = 0.270), NART-IQ (pBHadj = 
0.497), APOE (pBHadj = 0.153), FH (pBHadj = 0.520) or WHR (pBHadj = 0.330) and no interaction 
effects between APOE and FH (pBHadj = 0.436), APOE and WHR (pBHadj = 0.295) or APOE, 
FH and WHR (pBHadj = 0.228) were observed. 
 ODI post-hoc effects: Age-related increases in ODI were observed in left 
hippocampus, amygdala, caudate and right transverse temporal cortex (Table 5) (Figure 3).  
Post-hoc effects for the interaction between FH and WHR did not survive 5% FDR correction 
(Supplementary Table 2). 
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ICSF effects: There were no significant main or interaction effects on ICSF [age 
(pBHadj = 0.170), sex (pBHadj = 0.130), NART-IQ (pBHadj = 0.451), APOE (pBHadj = 0.324), FH 
(pBHadj = 0.342), WHR (pBHadj = 0.517), APOE x FH (pBHadj = 0.541), APOE x WHR(pBHadj = 
0.236) , FH x WHR (pBHadj = 0.883), APOE x FH x WHR (pBHadj = 0.912)]. 
 
2.3 MANCOVA on cortical thickness and subcortical volume (ICV corrected) 
Omnibus effects: There were main effects for age [F(82,68) = 1.8, pBHadj = 0.035, hp2 
= 0.7] and sex [F(82,68) = 1.9, pBHadj = 0.040, hp2 = 0.7]. No main effects were observed for 
APOE (pBHadj = 0.597), FH (pBHadj = 0.144), WHR (pBHadj = 0.152) or NART-IQ (pBHadj = 0.651). 
No interaction effects between APOE and FH (pBHadj = 0.844), APOE and WHR (pBHadj = 
0.978), FH and WHR (pBHadj = 0.053) or APOE, FH and WHR (pBHadj = 0.123) were observed. 
Post-hoc effects: Ageing was associated with widespread thinning in bilateral frontal, 
temporal, and parietal cortical regions as well as with volume loss in subcortical structures, 
i.e. in the left hippocampus, left nucleus accumbens, bilateral thalami and putamen (Table 6) 
(Figure 3). Women relative to men had larger volumes in left hippocampus, left nucleus 
accumbens, left putamen, right caudate and right pallidum. They also had larger cortical 
thickness in the right isthmus cingulate but lower cortical thickness in the left insula (Table 6) 
(Figure 2). 
 
2.4 Exploring interaction effects between APOE, age and sex 
Potential interaction effects between APOE, age and sex on left thalamus MPF were 
explored. Univariate analysis of variance revealed an effect of APOE [F(1,141) = 5.7, p = 
0.018] and age [F(2,141) = 3.7, p = 0.027] but no interaction effects between APOE and age 
(p = 0.700) or APOE and sex (p = 0.900). 
 
 
 
 11 
2.5 Exploring moderator effects of blood pressure and markers of inflammation 
We then explored with two separate analyses of covariances whether controlling for 
differences in i) systolic and diastolic blood pressure (BP) and ii) inflammation-related 
measures of C-Reactive Protein (CRP), Interleukin-8 (IL-8) and leptin/adiponectin ratio 
(LAR) would account for the effect of APOE on left thalamus MPF. 
While no covariate showed a main effect [systolic BP (p = 0.680), diastolic BP (p = 
0.750), CRP (p = 0.150), IL-8 (p = 0.400), LAR (p = 0.500)],  the APOE effect on the left 
thalamus MPF remained significant [F(1,149) = 6.7, pBHadj = 0.030] after accounting for BP 
measures, but was not significant anymore after controlling for CRP, IL-8 and LAR (p = 
0.060). 
 
3. Discussion  
 
Here, we investigated whether qMRI indices of apparent neurite density and 
dispersion, free water, myelin, and cell metabolism were sensitive to grey matter differences 
related to LOAD risk in cognitively healthy individuals. Such microstructural measurements 
hold the potential for novel imaging biomarkers to identify asymptomatic individuals at 
heightened risk of developing LOAD. As such they may provide non-invasive and cheaper 
alternatives to PET and CSF-based biomarkers, that are currently employed in clinical trials, 
in the future. 
The only significant difference between asymptomatic APOE-e4 carriers relative to 
non-carriers was in the qMT measure MPF in the left thalamus with APOE-e4 related 
reductions in MPF (Figure 1). This effect was observed independently of age, sex, and 
verbal intelligence. Reduced MPF may arise from processes that lead to an increase in free 
water and/or a reduction in the macromolecular content of grey matter including changes in 
myelin, proteins, and and/or iron concentrations69, 70. Such changes may be consistent with 
the presence of inflammatory processes leading to tissue swelling associated with glia 
activation71 and/or with a deficit in cholesterol transport in APOE-e4 carriers 72, 73 71. 
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Consistent with this interpretation we observed that the effect of APOE genotype on left 
thalamus MPF was moderated by plasma markers of inflammation (CRP, IL-8, LAR). 
Furthermore, evidence suggests that APOE-e4 carriage may increase susceptibility to 
inflammation 22, 23 and that inflammatory processes contribute significantly to the 
pathogenesis of LOAD74-76  
Notably these APOE-e4-related differences in MPF were only observed in the left 
thalamus but not in any other cortical or subcortical region. The limbic thalamic nuclei 
maintain dense reciprocal connections with the hippocampal formation and the retrosplenial 
cortex 77, 78, which, together with the fornix, mamillary bodies and posterior cingulate cortex, 
comprise the Papez circuit important for episodic memory function79.  As outlined above it is 
increasingly recognised that the Papez circuit, including the anterior thalamus, can be 
affected early in LOAD 4. Neurofibrillary accumulations are found in the anterodorsal 
thalamic nucleus at the same time as those in the hippocampus in LOAD brains 34 and 
neuroimaging studies have revealed reduced thalamic volume in both amnestic MCI 35 and 
LOAD 36. Furthermore, studies into the effects of APOE in middle-aged asymptomatic adults 
found reduced glucose metabolism in the thalamus, hippocampus and cingulate cortex 39 as 
well as increased metabolism in bilateral thalami and superior temporal gyrus in amyloid-b 
positive APOE-e4 carriers with a maternal history of LOAD 80. Cacciaglia et al. 81 studied the 
effects of APOE on grey matter volume in over 500 middle-aged asymptomatic individuals 
and identified reduced hippocampus, caudate, precentral gyrus, and cerebellum volumes but 
increased volumes in the thalamus, superior frontal and middle occipital gyri in APOE-e4 
carriers. While it remains unknown why APOE-e4 may be related to increased thalamic 
volume it was suggested that this could reflect brain swelling associated with glial activation 
in response to larger amyloid-β burden 82. As mentioned above, the here observed pattern of 
APOE-e4-related reductions in MPF in the left thalamus is consistent with this interpretation 
57, 83. One other study investigated the impact of APOE-e4 on qMT white matter metrics in 
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young adults and did not find any differences 84. This suggests that such risk-related glial 
dysfunction may accumulate with age and may only become apparent from midlife onwards. 
The question arises why we did not observe any risk-related effects in brain regions 
that have previously been reported to be affected by LOAD risk factors 10, 85 86. Reports with 
regards to the impact of APOE-e4 on grey matter structures in healthy young and middle-
aged adults have been mixed 10, 85, with some studies reporting no changes in hippocampal 
grey matter volume in APOE-e4 carriers 31, 87. Studies assessing the impact of APOE-e4 on 
tissue microstructure have primarily focused on diffusion tensor imaging (DTI) of white 
matter. While some reported widespread white matter differences in DTI measures 84, 88, 89, 
this has not been replicated in all studies 30, 90.  These discrepancies may arise due to DTI 
indices not being sufficiently sensitive and/or specific to detect early risk-related tissue 
abnormalities91. Direct comparisons between DTI and NODDI indices revealed that although 
fractional anisotropy (FA) was sensitive to white matter differences between healthy controls 
and patients with metabolic disease, FA was less anatomically specific and did not identify 
all brain regions that were captured by ICSF and ODI92. Thus we employed NODDI and qMT 
measurements to study risk effects on grey matter here and on white matter in a previous 
CARDS analysis93. In the previous white matter analysis93 we did not observe any main 
effects of risk but found that individuals with the highest genetic risk (obese FH+ and APOE-
e4) exhibited obesity-related reductions in MPF and ICSF in the right parahippocampal 
cingulum.  
Taken together, our findings demonstrate that MPF from qMT can identify risk-
related microstructural differences in limbic grey and white matter that were not apparent in 
conventional volumetric or cortical thickness measurements. We propose that these 
differences may reflect subtle changes related to neuroglia activation and that limbic 
structures including the thalamus are particularly susceptible to adverse effects of APOE-e4 
on glia cells. Inconsistencies in previous studies may have arisen from standard 
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morphological and DTI measurements not being sensitive and/or specific enough to detect 
such glia-related changes. 
It is important to note that while we did not find any risk-related effects on brain 
morphology we did replicate the well-established pattern of widespread age-related thinning 
in frontal, temporal and parietal regions 94 as well as volume loss in subcortical structures 
including the hippocampi and thalami (Figure 3). The subcortical volume loss was 
accompanied by age-related increases in ISOSF in bilateral hippocampi and thalami but 
effects on cortical regions were more localised: increased ISOSF was apparent along medial 
regions of the cingulate and parietal cortices including the precuneus as well as in superior 
temporal and lateral and orbito prefrontal cortices. Age-related increases in ISOSF have 
been previously observed 95 and most likely reflect lost tissue being replaced by 
cerebrospinal fluid (CSF). Consistent with a previous study 96 we also observed a positive 
correlation between age and ODI, an estimate of neurite dispersion, in the hippocampus and 
the left caudate and amygdala.  In contrast to Nazari et al. 96 however, we did not find any 
effects in cortical regions, while they reported reduced ODI with age in fronto-parietal 
regions. These opposing patterns in cortical and subcortical regions may reflect age-related 
reductions of neocortical dendritic spine density 97 with accompanying compensatory 
increases in the dendritic extent of dentate gyrus granular cells 98, 99. Similar age-related 
increases in the dendritic tree have also been reported in the basolateral nucleus of the 
amygdala of rats 100.  
Furthermore, we observed positive correlations between ISOSF and NART-IQ in 
superior temporal, parietal and lingual cortices that were partly driven by age. NART 
requires the reading of irregularly pronounced words and older relative to younger adults 
tended to perform better in the NART. However, positive albeit weak correlations between 
NART-IQ and ISOSF remained for the left superior temporal sulcus and left superior parietal 
cortex. Developmental imaging studies have revealed cortical thinning during adolescence 
that may be due to increased myelination101 or synaptic pruning and dendritic arborization102, 
103. It may therefore be possible that childhood developmental differences in cortical 
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maturation as well as in education may have contributed to this effect. For instance, 
childhood cognitive abilities have been found to account for relationships between cognitive 
performance and brain cortical thickness decades later in older adults from the Lothian birth 
cohort 104. 
Consistent with previous reports 105 we did not observe widespread sex-differences 
in brain morphology measurements with the exception of larger volumes in the left 
hippocampus in women than men 106. However, qMRI indices revealed the following pattern: 
Women compared to men, had lower ISOSF in widespread cortical and subcortical regions 
and larger MPF in frontal and temporal regions. Previously we also reported higher MPF and 
lower ISOSF for white matter in women than men 44. Overall this pattern of sex differences 
suggests higher cortical myelination and lower free water signal in women as they tended to 
be overall in better health i.e. were less obese, had lower systolic BP, and reported drinking 
less alcohol than men 44. All of these factors may have contributed to women showing 
“healthier” grey and white matter in the CARDS cohort. 
Finally, some study limitations need to be considered. First of all, CARDS is a cross-
sectional study that cannot answer whether the observed APOE effects on left thalamus 
MPF are predictive of accelerated development of LOAD pathology, cognitive, or neuronal 
decline.  Future prospective longitudinal studies are required to address this question. We 
also propose that our findings require replication in larger samples that can control for 
possible interactions between APOE and other LOAD risk genes such as variants of TREM2 
and polygenic risk hazards as the number of participants in the CARDS study was too small 
to do so. It is also worth mentioning that other qMRI measurements, that were not included 
in the current study, may prove helpful in characterising risk effects on the brain. Notably 
quantitative T2 and T2* measurements have been proposed to be sensitive to 
neurodegenerative processes. For instance, prolonged T2 relaxometry has been reported in 
the hippocampus of LOAD patients107 and has been proposed to increase the sensitivity and 
specificity of MCI and LOAD detection108. Finally, it should be noted that we only studied the 
thalamus as a whole structure while neuropathological evidence suggests a specific 
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vulnerability of the anterodorsal thalamic nucleus to LOAD pathology.  Future studies may 
investigate risk-related effects on specific subthalamic nuclei, which was beyond the scope 
of the current study as we were focusing on risk effects across the whole brain. 
In summary, we have shown APOE-e4 related reductions in the qMT measure MPF 
in the left thalamus that were moderated by peripheral markers of inflammation. This effect 
occurred independently of age, sex and NART-IQ and was not observed in morphological or 
microstructural indices from diffusion-weighted imaging. In addition, the effect was specific to 
the left thalamus and was not present in other cortical and subcortical grey matter regions. 
We propose that MPF reductions may reflect the effects of glia-mediated inflammatory and 
demyelination processes in APOE-e4 carriers. As such qMT measurements hold the 
potential for non-invasive and cheaper biomarker alternatives to PET, that may aid our 
understanding of the pathological processes leading to LOAD. In addition, qMT may help 
with the identification of asymptomatic individuals at heightened risk of LOAD for 
stratification into clinical trials for future preventative therapeutics.  
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4. Materials and Methods  
 
The Cardiff Ageing and Risk of Dementia Study (CARDS) has been described 
previously including a detailed description of the participant sample 43, 93, assessment of 
genetic and metabolic risk factors 44, 93 and the acquisition and processing of the MRI data 43, 
44, 93, 109. Here we provide a brief summary of the most important points. CARDS received 
ethical approval from the School of Psychology Research Ethics Committee at Cardiff 
University (EC.14.09.09.3843R2) and all participants provided written informed consent in 
accordance with the Declaration of Helsinki. All research methods were performed in line 
with Cardiff University’s Research Integrity and Governance Code of Practice and relevant 
data protection regulations. 
 
4.1 Participants 
The CARDS cohort comprised 166 community-dwelling individuals between the age 
of 38 and 71 years who underwent cognitive and health assessment as well as MRI 
scanning (Table 1). Exclusion criteria were a history of neurological and/or psychiatric 
disease, head injury, drug/alcohol dependency, high risk cardio-embolic source, large-vessel 
disease or MRI incompatibility due to pacemaker, stents or other surgical implants. As a 
group, participants intellectual functioning was above average as assessed with the National 
Adult Reading Test (NART) 67. All but one participant scored > 26 on the Mini Mental State 
Exam (MMSE) 110 thus the remaining 165 participants were classified as cognitively healthy. 
Eight participants scored ≥ 10 in the Patient Health Questionnaire (PHQ)-9 111, suggesting 
moderate levels of depression but no participant was severely depressed.  
 
4.2 Assessment of risk factors  
Saliva samples were collected with the Genotek Oragene-DNA kit (OG-500) and 
APOE genotypes ε2, ε3, and ε4 were determined with TaqMan genotyping of single 
nucleotide polymorphism (SNP) rs7412 and KASP genotyping of SNP rs429358. 
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Participants self-reported their family history of dementia, i.e., whether a first-grade relative 
was affected by Alzheimer’s disease, vascular dementia or any other type of dementia.  
Central obesity was assessed from the waist-hip ratio (WHR) 44 with abdominal obesity 
defined as a WHR ≥ 0.9 for males and ≥ 0.85 for females. Resting systolic and diastolic 
blood pressure (BP) readings were taken with a digital blood pressure monitor (Model UA-
631; A&D Medical, Tokyo, Japan) and the means of three readings were calculated. 
Participants self-reported other metabolic risk factors, including diabetes mellitus, high levels 
of blood cholesterol controlled with statin medication, history of smoking, and weekly alcohol 
intake. There were only few diabetics, smokers, and individuals on statins and, hence, these 
variables were not included in the analyses.  
 
4.3 Blood plasma analysis 
As previously reported 44, 93, venous blood samples were drawn into 9ml heparin 
coated plasma tubes after 12 hours overnight fasting and were centrifuged for 10 minutes at 
2,000xg within 1 hour from blood collection. Plasma samples were then transferred into 0.5 
ml polypropylene microtubes and stored in a freezer at -80°C. Circulating levels of high-
sensitivity C-Reactive Protein (CRP) in mg/dL were assayed using a human CRP Quantikine 
enzyme-linked immunosorbent assay (ELISA) kit (R & D Systems, Minneapolis, USA). Six 
individuals had a CRP value > 10 mg/ml indicative of acute infection and were, therefore, 
excluded from the statistical analyses testing for moderating effects of inflammation. Leptin 
concentrations in pg/ml were determined with the DRP300 Quantikine ELISA kit (R & D 
Systems) and adiponectin in ng/ml with the human total adiponectin/Acrp30 Quantitkine 
ELISA kit (R & D Systems). Leptin/adiponectin ratios for each participant were calculated. 
Interleukin IL-8 levels in pg/mL were determined using a high sensitivity CXCL8/ 
INTERLEUKIN-8 Quantikine ELISA kit (R & D Systems). Determination of interleukin-1β, 
interleukin-6 and Tumor Necrosis Factor α (TNFα) levels were trialled with high-sensitivity 
Quantikine ELISA kits but did not result in reliable measurements consistently above the 
level of detection for each assay 
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4.4 MRI data acquisition  
MRI data were acquired on a 3T MAGNETOM Prisma clinical scanner (Siemens 
Healthcare, Erlangen, Germany) as described in 43, 44, 93, 109.  T1-weighted images (1 x 1 x 1 
mm voxel) were collected with a three-dimension (3D) magnetization-prepared rapid 
gradient-echo (MP-RAGE) sequence (256 x 256 acquisition matrix, TR = 2300 ms, TE = 
3.06 ms, TI = 850ms, flip angle θ = 9°, 176 slices, 1mm slice thickness, FOV = 256 mm and 
acquisition time of ~ 6 min).  
High Angular Resolution Diffusion Imaging (HARDI) 51 data (2 x 2 x 2 mm voxel) 
were collected with a spin-echo echo-planar dual shell HARDI sequence with diffusion 
encoded along 90 isotropically distributed orientations 112 (30 directions at b-value = 1200 
s/mm2 and 60 directions at b-value = 2400 s/mm2) and six non-diffusion weighted scans with 
dynamic field correction and the following parameters: TR = 9400ms, TE = 67ms, 80 slices, 
2 mm slice thickness, FOV = 256 x 256 x 160 mm, GRAPPA acceleration factor = 2 and 
acquisition time of ~15 min. 
Quantitative magnetization transfer weighted imaging (qMT) data were acquired with 
a prototype sequence, i.e. an optimized 3D MT-weighted gradient-recalled-echo sequence 46 
to obtain magnetization transfer-weighted data with the following parameters: TR = 32 ms, 
TE = 2.46 ms; Gaussian MT pulses, duration t = 12.8 ms; FA = 5°; FOV = 24 cm, 2.5 x 2.5 x 
2.5 mm3 resolution. The following off-resonance irradiation frequencies (Θ) and their 
corresponding saturation pulse nominal flip angles (ΔSAT) for the 11 MT-weighted images 
were optimized using Cramer-Rao lower bound optimization: Θ = [1000 Hz, 1000 Hz, 2750 
Hz, 2768 Hz, 2790 Hz, 2890 Hz, 1000 Hz, 1000 Hz, 12060 Hz, 47180 Hz, 56360 Hz] and 
their corresponding ΔSAT values = [332°, 333°, 628°, 628°, 628°, 628°, 628°, 628°, 628°, 
628°, 332°]. The longitudinal relaxation time, T1, of the system was estimated by acquiring 
three 3D gradient recalled echo sequence (GRE) volumes with three different flip angles (θ = 
3°,7°,15°) using the same acquisition parameters as used in the MT-weighted sequence (TR 
= 32 ms, TE = 2.46 ms, FOV = 24 cm, 2.5 x 2.5 x 2.5 mm3 resolution). Data for computing 
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the static magnetic field (B0) were collected using two 3D GRE volumes with different echo-
times (TE = 4.92 ms and 7.38 ms respectively; TR= 330ms; FOV= 240 mm; slice thickness 
2.5 mm) 113. The acquisition time for the complete qMT sequence including all fieldmaps 
was ~30 min. 
 
4.5 HARDI and qMT data processing 
As described in 43, 44, 93, 109, the dual-shell HARDI data were split and b = 1200 and 
2400 s/mm2 data were corrected separately for distortions induced by the diffusion-weighted 
gradients and motion artifacts with appropriate reorientation of the encoding vectors 114 in 
ExploreDTI (Version 4.8.3) 115. EPI-induced geometrical distortions were corrected by 
warping the diffusion-weighted image volumes to the T1 –weighted anatomical images 116. 
After pre-processing, the NODDI model 45 was fitted to the HARDI data with the fast, linear 
model fitting algorithms of the Accelerated Microstructure Imaging via Convex Optimization 
(AMICO) framework 117 to gain ISOSF, ICSF, and ODI maps.  
Using Elastix 118, MT-weighted GRE volumes were co-registered to the MT-volume 
with the most contrast using a rigid body (6 degrees of freedom) registration to correct for 
inter-scan motion. Data from the 11 MT-weighted GRE images and T1-maps were fitted by a 
two-pool model using the Ramani pulsed-MT approximation 119.  This approximation 
provided MPF and kf maps. To remove voxels with noise-only data, MPF maps were 
thresholded to an upper intensity limit of 0.3 and kf maps to an upper limit of 3.0 using the 
fslmaths imaging calculator from the Functional Magnetic Resonance Imaging of the Brain 
(FMRIB) library (version 6).  
All image modality maps were spatially aligned to the T1-weighted anatomical volume 
as reference image with linear affine registration (12 degrees of freedom) using FMRIB’s 
Linear Image Registration Tool (FLIRT) 120, 121. 
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4.6 Cortical and subcortical grey matter region segmentation 
Grey matter cortical and subcortical regions were automatically segmented from T1- 
weighted images with the Freesurfer image analysis suite (version 5.3), which is 
documented online (https://surfer.nmr.mgh.harvard.edu/) 64. The images were processed by 
running the “recon-all” script using the default analysis settings. In brief, the images were 
registered to the Montreal Neurological Institute standard space and intensity normalization 
was performed. This was followed by automatic skull stripping to remove extracerebral 
structures, the cerebellum and the brain stem, followed by segmentation into grey matter 
(GM), white matter (WM) and cerebrospinal fluid (CSF) and separation of the hemispheres. 
Pial surfaces were obtained by tessellating the GM/WM matter boundary and by surface 
deformation following intensity gradients for optimal placement of GM/WM and GM/CSF 
boundaries 122. Surface inflation and registration to a spherical atlas were then performed 
and the cerebral cortex was parcellated into 34 regions per hemisphere based on gyral and 
sulcal structures following the Desikan-Killiany atlas 123. Cortical thickness measurements 
were estimated as the average shortest distance between the pial surface and the WM 
boundary 124. For each hemisphere, seven deep grey matter structures (hippocampus, 
amygdala, thalamus, caudate, putamen, pallidum, and nucleus accumbens) were 
automatically parcellated using a probabilistic atlas so that average volumetric 
measurements could be determined 125. Mean intracranial volume fractions (ICV) were 
extracted for each brain as estimates of individual differences in head sizes and all 
volumetric measurements were adjusted for ICV by dividing each participant’s subcortical 
volume by their ICV. 
Finally, the mean values of all microstructural indices were extracted from each 
participants’ cortical and subcortical region of interests. Mean measurements were taken in 
each participants’ native space. This was done by first converting each participants’ cortical 
and subcortical masks from the FreeSurfer Massachusetts General Hospital volume file 
format (MGZ) into the Neuroimaging Informations Technology Initiative (NIfTI) analyze-style 
data format and then uploading the microstructural maps onto each region of interest mask 
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using the fslmaths command from the FMRIB library. Mean values of each index for each 
mask were then extracted using the FMRIB fslstats command. NODDI and qMT indices of 
ISOSF, ICSF, ODI, MPF and kf, could not be extracted from bilateral caudal middle frontal, 
left isthmus cingulate and left pericalcarine regions and R1 could not be extracted from the 
right postcentral region. 
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Table 1. Summary of demographic, genetic, and lifestyle risk information of CARDS 
participants. 
 Mean (SD) (range) 
Sample size n 165 
Age (in years) 55.7 (8.2) (38 – 71) 
Females 57% 
NART-IQ 116.8 (6.7) (96 – 128) 
MMSE  29.1 (0.9) (27 – 30) 
FH+  35.8% 
APOE4+  38.8%  
WHR  1.4 (0.5) (0.7 – 2.2) 
Systolic BP (mm Hg) 132 (18.8) (68.3 – 196) 
Diastolic BP (mm Hg) 83.3 (9.4) (58.7 – 118.7) 
Smokers 5.5% 
Diabetes 1.8% 
Alcohol units per week 7.4 (9.4) (0 – 60) 
PHQ-9 Depression score  2.6 (2.9) (0 -13) 
APOE = Apolipoprotein-E based on DNA extraction and APOE genotyping of saliva samples 
using TaqMan genotyping of single nucleotide polymorphism (SNP) rs7412 and KASP 
genotyping of SNP rs429358. FH = Family History of a first degree relative affected by 
Alzheimer’s or Lewy body disease or vascular dementia.  MMSE = Mini Mental State Exam 
(maximum score = 30)110, NART-IQ = National Adult Reading Test- Intelligence Quotient 67, 
PHQ-9 = Patient Health Questionnaire (maximum score = 27) 111. WHR = Waist-to-Hip-Ratio 
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Table 2. Overview of the quantitative microstructural indices and their interpretation in 
grey matter 
MRI modality Index Apparent grey matter 
property 
Hypothesised changes 
with LOAD risk 
Diffusion NODDI ICSF Neurite density Increases with tau 
pathology (Colgan et al, 
2016) 
 ODI Neurite dispersion Increase 
 ISOSF Free water Increase  
qMT MPF Macromolecules (e.g. 
myelin)  
Reduction 
 kf Mitochondrial 
metabolism 
Increase in acute 
inflammation (Harrison et 
al., 2015); 
Reduction in low-level 
inflammation 126 
Relaxometry R1 free water, myelin, iron Reduction 
Abbreviations: ICSF = intracellular signal fraction, ISOSF = isotropic signal fraction, kf = 
forward exchange rate, MPF = macromolecular proton fraction, NODDI = neurite orientation 
dispersion and density imaging, ODI = orientation dispersion index, qMT = quantitative 
magnetization transfer. 
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Table 3. Post-hoc effects of APOE genotype and sex on the macromolecular proton fraction 
(MPF). 
Effect Side ROI F(1,123)-value pBHadj 
APOE left accumbens 3.985 0.214 
amygdala 0.171 0.869 
caudate 6.710 0.090 
hippocampus 5.327 0.143 
pallidum 0.099 0.891 
putamen 1.416 0.511 
thalamus 10.772 0.026 
right accumbens 0.310 0.790 
amygdala 0.125 0.868 
caudate 3.433 0.264 
hippocampus 6.700 0.095 
pallidum 0.039 0.919 
putamen 1.226 0.561 
thalamus 5.233 0.144 
left banks of superior temporal sulcus 3.424 0.261 
caudal anterior cingulate 1.518 0.483 
cuneus 0.631 0.689 
entorhinal 0.002 0.986 
frontal pole 2.579 0.320 
fusiform 0.771 0.669 
inferior parietal 0.886 0.631 
inferior temporal 0.942 0.635 
insula 6.754 0.097 
lateral occipital 0.307 0.788 
lateral orbito frontal 0.355 0.777 
lingual 0.641 0.690 
medial orbito frontal 0.001 0.993 
middle temporal 2.653 0.318 
paracentral 0.035 0.924 
parahippocampal 0.150 0.865 
pars opercularis 8.341 0.097 
pars orbitalis 0.028 0.932 
pars triangularis 0.019 0.945 
postcentral 2.459 0.331 
posterior cingulate 1.065 0.592 
precentral 3.040 0.297 
precuneus 0.000 0.997 
rostral anterior cingulate 0.531 0.714 
rostral middle frontal 0.112 0.880 
superior frontal 0.515 0.719 
superior parietal 0.222 0.836 
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superior temporal 1.096 0.594 
supramarginal 2.657 0.312 
temporal pole 3.597 0.252 
transverse temporal 5.752 0.117 
right banks of superior temporal sulcus 0.085 0.892 
caudal anterior cingulate 6.693 0.100 
cuneus 0.077 0.897 
entorhinal 0.088 0.892 
frontal pole 0.070 0.882 
fusiform 2.047 0.416 
inferior parietal 0.736 0.673 
inferior temporal 0.162 0.865 
insula 4.235 0.198 
isthmus cingulate 0.927 0.635 
lateral occipital 0.072 0.891 
lateral orbito frontal 0.785 0.668 
lingual 3.499 0.262 
medial orbito frontal 1.979 0.407 
middle temporal 0.130 0.876 
paracentral 0.071 0.887 
parahippocampal 1.994 0.409 
pars opercularis 1.551 0.493 
pars orbitalis 0.511 0.714 
pars triangularis 0.001 0.986 
pericalcerine 0.875 0.629 
postcentral 0.074 0.895 
posterior cingulate 1.341 0.532 
precentral 0.303 0.784 
precuneus 0.198 0.854 
rostral anterior cingulate 1.850 0.429 
rostral middle frontal 0.151 0.858 
superior frontal 0.026 0.932 
superior parietal 1.548 0.488 
superior temporal 1.148 0.579 
supramarginal 0.167 0.866 
temporal pole 0.764 0.665 
transverse temporal 0.155 0.867 
 
Sex left accumbens 0.353 0.784 
amygdala 0.014 0.956 
caudate 1.918 0.418 
hippocampus 0.684 0.673 
pallidum 1.079 0.594 
putamen 2.12 0.405 
thalamus 2.668 0.321 
right accumbens 0.126 0.874 
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amygdala 0.000 0.993 
caudate 0.046 0.912 
hippocampus 0.223 0.842 
pallidum 0.697 0.673 
putamen 2.678 0.324 
thalamus 0.571 0.710 
left banks of superior temporal sulcus 0.559 0.711 
caudal anterior cingulate 0.459 0.742 
cuneus 7.712 0.093 
entorhinal 5.902 0.115 
frontal pole 4.243 0.204 
fusiform 0.007 0.971 
inferior parietal 6.242 0.104 
inferior temporal 0.191 0.854 
insula 1.298 0.541 
lateral occipital 0.063 0.888 
lateral orbito frontal 0.002 0.992 
lingual 3.095 0.293 
medial orbito frontal 2.921 0.298 
middle temporal 2.496 0.331 
paracentral 0.009 0.968 
parahippocampal 7.180 0.104 
pars opercularis 1.169 0.578 
pars orbitalis 1.524 0.488 
pars triangularis 7.929 0.085 
postcentral 0.903 0.638 
posterior cingulate 15.379 < 0.001 
precentral 0.726 0.664 
precuneus 4.327 0.201 
rostral anterior cingulate 0.727 0.669 
rostral middle frontal 18.725 < 0.001 
superior frontal 4.349 0.202 
superior parietal 1.629 0.474 
superior temporal 13.584 < 0.001 
supramarginal 7.837 0.104 
temporal pole 3.766 0.238 
transverse temporal 7.374 0.096 
right banks of superior temporal sulcus 2.881 0.292 
caudal anterior cingulate 4.038 0.215 
cuneus 7.177 0.089 
entorhinal 2.004 0.413 
frontal pole 4.610 0.196 
fusiform 0.097 0.886 
inferior parietal 1.757 0.442 
inferior temporal 0.352 0.771 
insula 2.943 0.308 
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isthmus cingulate 0.443 0.746 
lateral occipital 0.297 0.782 
lateral orbito frontal 0.356 0.790 
lingual 3.196 0.289 
medial orbito frontal 4.570 0.195 
middle temporal 0.360 0.793 
paracentral 0.425 0.752 
parahippocampal 0.975 0.625 
pars opercularis 0.340 0.774 
pars orbitalis 0.892 0.636 
pars triangularis 6.046 0.106 
pericalcerine 0.553 0.708 
postcentral 2.934 0.301 
posterior cingulate 1.783 0.441 
precentral 2.025 0.415 
precuneus 0.597 0.702 
rostral anterior cingulate 3.205 0.282 
rostral middle frontal 11.339 0.031 
superior frontal 8.639 0.089 
superior parietal 4.557 0.188 
superior temporal 7.319 0.083 
supramarginal 2.903 0.295 
temporal pole 6.534 0.093 
transverse temporal 14.344 <0.001 
pBHadj, 5% False Discovery Rate Benjamini-Hochberg adjusted p-value; ROI, Region of 
Interest. Significant results are highlighted in bold.   
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Table 4. Post-hoc effects of age, sex and NART-IQ on the isotropic signal fraction (ISOSF). 
Effect Side ROI F(1,119)-value pBHadj 
Age left accumbens 16.946 <0.001 
amygdala 0.002 0.977 
caudate 2.906 0.174 
hippocampus 32.296 <0.001 
pallidum 0.741 0.544 
putamen 3.705 0.121 
thalamus 17.881 <0.001 
right accumbens 8.272 0.016 
amygdala 0.090 0.847 
caudate 4.359 0.090 
hippocampus 20.305 <0.001 
pallidum 0.168 0.787 
putamen 6.089 0.039 
thalamus 21.716 <0.001 
left banks of superior temporal sulcus 12.121 0.003 
caudal anterior cingulate 12.152 0.004 
cuneus 17.203 <0.001 
entorhinal 0.170 0.788 
frontal pole 0.667 0.559 
fusiform 0.884 0.494 
inferior parietal 6.381 0.035 
inferior temporal 0.765 0.538 
insula 17.457 <0.001 
lateral occipital 6.671 0.031 
lateral orbito frontal 3.029 0.163 
lingual 2.481 0.212 
medial orbito frontal 6.335 0.035 
middle temporal 11.334 0.004 
paracentral 4.216 0.095 
parahippocampal 0.125 0.819 
pars opercularis 19.568 <0.001 
pars orbitalis 0.005 0.961 
pars triangularis 15.445 <0.001 
postcentral 14.471 <0.001 
posterior cingulate 15.798 <0.001 
precentral 5.314 0.057 
precuneus 19.354 <0.001 
rostral anterior cingulate 16.241 <0.001 
rostral middle frontal 5.017 0.067 
superior frontal 1.173 0.410 
superior parietal 0.963 0.470 
superior temporal 25.891 <0.001 
supramarginal 16.621 <0.001 
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temporal pole 1.219 0.410 
transverse temporal 51.576 <0.001 
right banks of superior temporal sulcus 12.346 0.003 
caudal anterior cingulate 7.267 0.025 
cuneus 13.388 <0.001 
entorhinal 0.131 0.819 
frontal pole 1.185 0.414 
fusiform 0.108 0.835 
inferior parietal 1.881 0.297 
inferior temporal 1.475 0.366 
insula 14.803 <0.001 
isthmus cingulate 6.659 0.031 
lateral occipital 1.818 0.307 
lateral orbito frontal 1.286 0.406 
lingual 7.195 0.024 
medial orbito frontal 3.288 0.147 
middle temporal 3.039 0.165 
paracentral 0.702 0.556 
parahippocampal 1.158 0.412 
pars opercularis 15.415 <0.001 
pars orbitalis 2.665 0.195 
pars triangularis 0.523 0.605 
pericalcerine 16.505 <0.001 
postcentral 6.318 0.034 
posterior cingulate 18.89 <0.001 
precentral 4.015 0.104 
precuneus 15.968 <0.001 
rostral anterior cingulate 12.476 0.003 
rostral middle frontal 2.466 0.212 
superior frontal 0.676 0.550 
superior parietal 3.634 0.124 
superior temporal 12.296 0.003 
supramarginal 8.563 0.013 
temporal pole 2.727 0.189 
transverse temporal 44.346 <0.001 
 
Sex left accumbens 4.687 0.078 
amygdala 0.320 0.693 
caudate 6.885 0.029 
hippocampus 30.457 <0.001 
pallidum 3.735 0.120 
putamen 0.886 0.497 
thalamus 6.685 0.031 
right accumbens 10.982 0.003 
amygdala 3.110 0.161 
caudate 8.610 0.013 
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hippocampus 37.739 <0.001 
pallidum 1.177 0.412 
putamen 0.595 0.577 
thalamus 28.188 <0.001 
left banks of superior temporal sulcus 9.745 0.007 
caudal anterior cingulate 10.321 0.007 
cuneus 14.189 <0.001 
entorhinal 2.097 0.263 
frontal pole 1.317 0.400 
fusiform 0.471 0.621 
inferior parietal 19.193 <0.001 
inferior temporal 3.546 0.129 
insula 14.093 <0.001 
lateral occipital 15.940 <0.001 
lateral orbito frontal 0.039 0.902 
lingual 1.178 0.414 
medial orbito frontal 3.411 0.138 
middle temporal 17.995 <0.001 
paracentral 1.542 0.355 
parahippocampal 14.537 <0.001 
pars opercularis 11.519 0.003 
pars orbitalis 0.167 0.784 
pars triangularis 16.204 <0.001 
postcentral 28.162 <0.001 
posterior cingulate 16.237 <0.001 
precentral 22.987 <0.001 
precuneus 13.571 <0.001 
rostral anterior cingulate 4.385 0.088 
rostral middle frontal 35.530 <0.001 
superior frontal 13.064 <0.001 
superior parietal 18.143 <0.001 
superior temporal 26.621 <0.001 
supramarginal 42.479 <0.001 
temporal pole 4.436 0.088 
transverse temporal 30.601 <0.001 
right banks of superior temporal sulcus 14.697 <0.001 
caudal anterior cingulate 10.623 0.004 
cuneus 24.330 <0.001 
entorhinal 0.491 0.616 
frontal pole 0.684 0.557 
fusiform 3.168 0.158 
inferior parietal 6.885 0.030 
inferior temporal 3.105 0.162 
insula 4.265 0.094 
isthmus cingulate 0.601 0.578 
lateral occipital 10.275 0.006 
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lateral orbito frontal 0.102 0.839 
lingual 7.981 0.019 
medial orbito frontal 3.038 0.166 
middle temporal 5.352 0.055 
paracentral 9.075 0.010 
parahippocampal 3.733 0.121 
pars opercularis 7.161 0.027 
pars orbitalis 3.870 0.112 
pars triangularis 5.958 0.042 
pericalcerine 14.080 <0.001 
postcentral 19.109 <0.001 
posterior cingulate 14.954 <0.001 
precentral 17.777 <0.001 
precuneus 13.291 <0.001 
rostral anterior cingulate 5.785 0.046 
rostral middle frontal 24.380 <0.001 
superior frontal 16.120 <0.001 
superior parietal 8.266 0.016 
superior temporal 16.902 <0.001 
supramarginal 16.983 <0.001 
temporal pole 0.330 0.691 
transverse temporal 37.792 <0.001 
 
NART-IQ left accumbens 0.709 0.556 
amygdala 3.741 0.120 
caudate 0.016 0.932 
hippocampus 0.065 0.864 
pallidum 0.022 0.922 
putamen 1.221 0.411 
thalamus 0.000 0.995 
right accumbens 0.022 0.924 
amygdala 1.266 0.410 
caudate 1.809 0.306 
hippocampus 0.067 0.866 
pallidum 0.206 0.764 
putamen 0.606 0.579 
thalamus 0.481 0.618 
left banks of superior temporal sulcus 6.816 0.029 
caudal anterior cingulate 0.035 0.901 
cuneus 0.200 0.767 
entorhinal 0.343 0.684 
frontal pole 1.745 0.315 
fusiform 0.039 0.904 
inferior parietal 2.029 0.274 
inferior temporal 0.019 0.925 
insula 4.834 0.073 
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lateral occipital 0.306 0.697 
lateral orbito frontal 0.037 0.901 
lingual 0.621 0.574 
medial orbito frontal 0.000 0.993 
middle temporal 0.402 0.655 
paracentral 0.199 0.764 
parahippocampal 0.010 0.943 
pars opercularis 0.207 0.768 
pars orbitalis 1.006 0.459 
pars triangularis 0.636 0.570 
postcentral 1.370 0.388 
posterior cingulate 1.243 0.411 
precentral 0.401 0.653 
precuneus 0.078 0.852 
rostral anterior cingulate 0.582 0.581 
rostral middle frontal 1.208 0.411 
superior frontal 1.224 0.414 
superior parietal 6.435 0.033 
superior temporal 0.266 0.724 
supramarginal 0.879 0.493 
temporal pole 0.084 0.849 
transverse temporal 2.832 0.180 
right banks of superior temporal sulcus 6.815 0.030 
caudal anterior cingulate 0.530 0.605 
cuneus 2.829 0.179 
entorhinal 4.702 0.077 
frontal pole 1.644 0.332 
fusiform 2.222 0.246 
inferior parietal 2.952 0.170 
inferior temporal 0.001 0.987 
insula 0.090 0.843 
isthmus cingulate 1.257 0.409 
lateral occipital 0.126 0.821 
lateral orbito frontal 0.014 0.933 
lingual 5.866 0.044 
medial orbito frontal 0.318 0.692 
middle temporal 0.097 0.842 
paracentral 2.527 0.208 
parahippocampal 1.983 0.280 
pars opercularis 0.242 0.741 
pars orbitalis 0.050 0.888 
pars triangularis 0.502 0.613 
pericalcerine 2.623 0.198 
postcentral 1.806 0.306 
posterior cingulate 1.662 0.331 
precentral 0.685 0.559 
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precuneus 2.629 0.197 
rostral anterior cingulate 0.453 0.628 
rostral middle frontal 0.394 0.653 
superior frontal 1.525 0.355 
superior parietal 4.186 0.096 
superior temporal 0.002 0.978 
supramarginal 1.407 0.381 
temporal pole 4.445 0.087 
transverse temporal 0.024 0.923 
pBHadj, 5% False Discovery Rate Benjamini-Hochberg adjusted p-value; ROI, Region of 
Interest. Significant results are highlighted in bold.    
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Table 5. Post-hoc effects of age on the orientation dispersion index (ODI). 
Effect Side ROI F(1,128)-value pBHadj 
Age left accumbens 3.529 0.307 
amygdala 16.646 <0.001 
caudate 13.995 <0.001 
hippocampus 15.638 <0.001 
pallidum 0.017 0.958 
putamen 3.880 0.306 
thalamus 2.111 0.505 
right accumbens 1.265 0.594 
amygdala 7.018 0.156 
caudate 0.040 0.925 
hippocampus 8.834 0.124 
pallidum 0.365 0.755 
putamen 2.142 0.506 
thalamus 0.148 0.828 
left banks of superior temporal sulcus 2.793 0.398 
caudal anterior cingulate 7.199 0.156 
cuneus 0.001 0.992 
entorhinal 5.518 0.222 
frontal pole 2.182 0.515 
fusiform 2.889 0.387 
inferior parietal 0.029 0.943 
inferior temporal 1.654 0.559 
insula 0.579 0.698 
lateral occipital 1.619 0.563 
lateral orbito frontal 1.572 0.560 
lingual 0.919 0.616 
medial orbito frontal 5.107 0.253 
middle temporal 1.088 0.598 
paracentral 0.634 0.693 
parahippocampal 0.173 0.826 
pars opercularis 0.076 0.892 
pars orbitalis 2.068 0.507 
pars triangularis 0.055 0.914 
postcentral 0.526 0.705 
posterior cingulate 1.419 0.575 
precentral 0.305 0.776 
precuneus 0.063 0.907 
rostral anterior cingulate 1.459 0.576 
rostral middle frontal 2.006 0.496 
superior frontal 1.109 0.595 
superior parietal 4.078 0.326 
superior temporal 2.666 0.409 
supramarginal 0.291 0.760 
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temporal pole 8.362 0.130 
transverse temporal 0.200 0.817 
right banks of superior temporal sulcus 0.534 0.712 
caudal anterior cingulate 2.715 0.408 
cuneus 0.628 0.691 
entorhinal 1.911 0.516 
frontal pole 3.977 0.312 
fusiform 2.329 0.479 
inferior parietal 0.004 0.984 
inferior temporal 4.430 0.288 
insula 4.760 0.268 
isthmus cingulate 5.750 0.216 
lateral occipital 1.311 0.591 
lateral orbito frontal 1.274 0.598 
lingual 0.173 0.819 
medial orbito frontal 0.734 0.666 
middle temporal 4.509 0.295 
paracentral 0.899 0.611 
parahippocampal 0.373 0.754 
pars opercularis 2.490 0.445 
pars orbitalis 1.778 0.544 
pars triangularis 0.023 0.952 
pericalcerine 0.293 0.765 
postcentral 1.564 0.553 
posterior cingulate 0.042 0.926 
precentral 0.100 0.870 
precuneus 0.000 0.985 
rostral anterior cingulate 0.284 0.760 
rostral middle frontal 0.268 0.768 
superior frontal 0.485 0.716 
superior parietal 3.130 0.352 
superior temporal 5.045 0.238 
supramarginal 1.426 0.581 
temporal pole 6.156 0.198 
transverse temporal 10.589 0.039 
pBHadj, 5% False Discovery Rate Benjamini-Hochberg adjusted p-value; ROI, Region of 
Interest. Significant results are highlighted in bold.   
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Table 6 Post-hoc effects of age and sex on cortical thickness and subcortical volume 
measures. 
Effect Side ROI Index F(1,149)-
value 
pBHadj 
Age left accumbens VolICVadj 7.037 0.027 
amygdala VolICVadj 3.360 0.146 
caudate VolICVadj 0.073 0.873 
hippocampus VolICVadj 12.023 0.004 
pallidum VolICVadj 1.141 0.448 
putamen VolICVadj 8.886 0.012 
thalamus VolICVadj 26.144 <0.001 
right accumbens VolICVadj 4.944 0.071 
amygdala VolICVadj 3.723 0.120 
caudate VolICVadj 0.225 0.778 
hippocampus VolICVadj 2.828 0.190 
pallidum VolICVadj 2.444 0.221 
putamen VolICVadj 7.722 0.021 
thalamus VolICVadj 45.557 <0.001 
left banks of superior temporal sulcus CT 5.798 0.047 
caudal anterior cingulate CT 0.583 0.589 
caudal middle frontal CT 8.485 0.016 
cuneus CT 3.911 0.110 
entorhinal CT 0.120 0.836 
frontal pole CT 0.076 0.885 
fusiform CT 5.474 0.057 
inferior parietal CT 11.874 0.004 
inferior temporal CT 7.261 0.027 
insula CT 20.522 <0.001 
isthmus cingulate CT 0.130 0.836 
lateral occipital CT 4.536 0.086 
lateral orbito frontal CT 12.478 0.006 
lingual CT 6.891 0.030 
medial orbito frontal CT 7.171 0.026 
middle temporal CT 12.759 <0.001 
paracentral CT 20.354 <0.001 
parahippocampal CT 7.647 0.022 
pars opercularis CT 14.469 <0.001 
pars orbitalis CT 18.893 <0.001 
pars triangularis CT 19.089 <0.001 
pericalcerine CT 2.678 0.203 
postcentral CT 12.426 0.006 
posterior cingulate CT 1.032 0.467 
precentral CT 28.246 <0.001 
precuneus CT 12.353 0.006 
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rostral anterior cingulate CT 7.759 0.022 
rostral middle frontal CT 13.280 <0.001 
superior frontal CT 24.962 <0.001 
superior parietal CT 9.821 0.009 
superior temporal CT 27.155 <0.001 
supramarginal CT 22.159 <0.001 
temporal pole CT 0.682 0.555 
transverse temporal CT 2.574 0.211 
right banks of superior temporal sulcus CT 11.955 0.006 
caudal anterior cingulate CT 3.192 0.150 
caudal middle frontal CT 2.576 0.209 
cuneus CT 1.553 0.363 
entorhinal CT 0.121 0.840 
frontal pole CT 0.015 0.938 
fusiform CT 18.048 <0.001 
inferior parietal CT 22.640 <0.001 
inferior temporal CT 9.714 0.008 
insula CT 12.353 0.005 
isthmus cingulate CT 4.464 0.088 
lateral occipital CT 4.184 0.099 
lateral orbito frontal CT 13.295 <0.001 
lingual CT 7.316 0.026 
medial orbito frontal CT 6.738 0.029 
middle temporal CT 18.517 <0.001 
paracentral CT 17.110 <0.001 
parahippocampal CT 8.659 0.015 
pars opercularis CT 12.395 0.005 
pars orbitalis CT 12.59 0.005 
pars triangularis CT 19.087 <0.001 
pericalcerine CT 2.454 0.221 
postcentral CT 7.200 0.025 
posterior cingulate CT 6.381 0.038 
precentral CT 10.001 0.009 
precuneus CT 15.729 <0.001 
rostral anterior cingulate CT 1.949 0.290 
rostral middle frontal CT 10.641 0.005 
superior frontal CT 18.426 <0.001 
superior parietal CT 7.745 0.021 
superior temporal CT 19.439 <0.001 
supramarginal CT 10.607 0.005 
temporal pole CT 0.020 0.950 
transverse temporal CT 1.548 0.359 
 
Sex left accumbens VolICVadj 8.927 0.012 
amygdala VolICVadj 0.074 0.878 
caudate VolICVadj 4.492 0.086 
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hippocampus VolICVadj 10.913 0.007 
pallidum VolICVadj 1.649 0.343 
putamen VolICVadj 6.103 0.042 
thalamus VolICVadj 1.934 0.289 
right accumbens VolICVadj 3.833 0.113 
amygdala VolICVadj 0.513 0.623 
caudate VolICVadj 7.183 0.025 
hippocampus VolICVadj 4.695 0.080 
pallidum VolICVadj 7.633 0.020 
putamen VolICVadj 4.265 0.096 
thalamus VolICVadj 4.360 0.090 
left banks of superior temporal sulcus CT 3.183 0.157 
caudal anterior cingulate CT 0.019 0.935 
caudal middle frontal CT 0.018 0.934 
cuneus CT 1.857 0.302 
entorhinal CT 0.075 0.881 
frontal pole CT 0.794 0.519 
fusiform CT 0.285 0.761 
inferior parietal CT 2.104 0.268 
inferior temporal CT 0.229 0.780 
insula CT 9.485 0.008 
isthmus cingulate CT 0.031 0.928 
lateral occipital CT 0.244 0.772 
lateral orbito frontal CT 0.058 0.886 
lingual CT 0.891 0.503 
medial orbito frontal CT 1.146 0.455 
middle temporal CT 0.206 0.783 
paracentral CT 2.266 0.244 
parahippocampal CT 0.936 0.490 
pars opercularis CT 1.245 0.436 
pars orbitalis CT 0.134 0.837 
pars triangularis CT 2.647 0.204 
pericalcerine CT 0.202 0.782 
postcentral CT 4.122 0.100 
posterior cingulate CT 0.295 0.759 
precentral CT 0.008 0.948 
precuneus CT 0.098 0.859 
rostral anterior cingulate CT 0.038 0.917 
rostral middle frontal CT 0.019 0.941 
superior frontal CT 1.171 0.451 
superior parietal CT 0.459 0.649 
superior temporal CT 0.141 0.835 
supramarginal CT 4.028 0.105 
temporal pole CT 1.133 0.447 
transverse temporal CT 1.466 0.377 
right banks of superior temporal sulcus CT 3.084 0.166 
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caudal anterior cingulate CT 0.069 0.872 
caudal middle frontal CT 0.809 0.527 
cuneus CT 0.855 0.513 
entorhinal CT 0.746 0.536 
frontal pole CT 1.243 0.433 
fusiform CT 0.799 0.522 
inferior parietal CT 5.173 0.063 
inferior temporal CT 0.019 0.946 
insula CT 5.346 0.059 
isthmus cingulate CT 6.254 0.037 
lateral occipital CT 0.625 0.574 
lateral orbito frontal CT 2.769 0.193 
lingual CT 0.267 0.770 
medial orbito frontal CT 0.941 0.493 
middle temporal CT 0.167 0.811 
paracentral CT 2.089 0.267 
parahippocampal CT 1.127 0.444 
pars opercularis CT 0.993 0.478 
pars orbitalis CT 0.670 0.556 
pars triangularis CT 0.007 0.944 
pericalcerine CT 0.008 0.959 
postcentral CT 2.954 0.178 
posterior cingulate CT 0.704 0.550 
precentral CT 0.252 0.771 
precuneus CT 0.806 0.524 
rostral anterior cingulate CT 1.115 0.444 
rostral middle frontal CT 0.008 0.953 
superior frontal CT 0.003 0.959 
superior parietal CT 4.903 0.072 
superior temporal CT 0.220 0.777 
supramarginal CT 1.145 0.451 
temporal pole CT 0.005 0.951 
transverse temporal CT 0.262 0.768 
Abbreviations: CT, Cortical Thickness; VolICVadj, Volume adjusted for intracranial volume.  
pBHadj, 5% False Discovery Rate Benjamini-Hochberg adjusted p-value; ROI, Region of 
Interest. 
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Figure legends 
 
Figure 1 Violin plots with overlaid box plots of the difference in the macromolecular proton 
fraction (MPF) in the left thalamus between APOE-e4 carriers (n = 57) and non-carriers (n = 
97) (pBHadj = 0.026). Boxplots display the median and the interquartile range and violin plots 
the kernel probability density, i.e. the width of the yellow area represents the proportion of 
the data located there. 
 
Figure 2 displays the effects of sex on cortical thickness (CT), subcortical volume (corrected 
for intracranial volume), isotropic signal fraction (ISOSF) and macromolecular proton fraction 
(MPF) across 34 cortical regions per hemisphere parcellated with the Desikan-Killiany atlas 
123 and seven subcortical regions per hemisphere (hippocampus, amygdala, thalamus, 
caudate, putamen, globus pallidus, nucleus accumbens). Region of interest segmentations 
were performed with FreeSurfer (version 5.3). Regions are colour-coded according to effect 
sizes indicated by Cohen’s d 127. Warm colours indicate positive and blue colours negative 
correlations. L = Left, R = Right. 
 
 
Figure 3 displays the effects of age on cortical thickness (CT), subcortical volume (corrected 
for intracranial volume), isotropic signal fraction (ISOSF) and orientation dispersion index 
(ODI) across 34 cortical regions per hemisphere parcellated with the Desikan-Killiany atlas 
123 and seven subcortical regions per hemisphere (hippocampus, amygdala, thalamus, 
caudate, putamen, globus pallidus, nucleus accumbens). Region of interest segmentations 
were performed with FreeSurfer (version 5.3). Regions are colour-coded according to the 
size of the age effect indicated by Pearson correlation coefficient r. Warm colours indicate 
positive and blue colours negative correlations.  
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